Related by context. All words. (Click for frequent words.) 73 rxRNA 72 inhaled AAT 72 Onconase 72 liposomal formulation 71 PDE4 inhibitor 71 novel oral anticoagulant 71 mertansine 71 Archexin 71 targeted radiotherapeutic 71 Pimavanserin 70 Spiegelmer ® 70 Safinamide 70 Curaxin 70 proteasome inhibitor 70 Maribavir 70 JAK inhibitor 70 EP #R 69 Squalamine 69 ibudilast 69 Fc fusion protein 69 ARIKACE ™ 69 mGluR2 NAM 69 intranasal formulation 69 Panzem 69 immunotherapeutic vaccine 69 OvaRex R 69 BNC# 69 generation purine nucleoside 69 HDL Selective Delipidation 69 trodusquemine 69 MAGE A3 ASCI 69 Interferon beta 69 Tasimelteon 69 cannabinor 69 metaglidasen 69 biologic therapeutics 69 Factor VIIa 69 omacetaxine mepesuccinate 69 reslizumab 68 humanized monoclonal 68 INS# [001] 68 AZILECT ® 68 Aflibercept 68 vidofludimus 68 oral prodrug 68 SNT MC# 68 Alvesco R 68 VitiGam 68 selective adenosine 68 PEGylated interferon 68 OHR/AVR# 68 Dalbavancin 68 ONCONASE R 68 R#/MEM # 68 Ketotransdel 68 Lixivaptan 68 RhuDex ® 68 Panzem ® 68 Silodosin 68 ATL# [002] 68 tezampanel NGX# 68 Leukine ® 68 therapeutic monoclonal antibody 68 PrevOnco 68 PHX# 68 Xanafide 68 oral salmon calcitonin 68 Phase Ib study 68 selective androgen receptor modulator 68 Angiocept 67 Alexza Staccato 67 ProSavin 67 Dual Opioid TM 67 Panzem R 67 PD LID 67 beta secretase inhibitors 67 Daclizumab 67 ALN TTR# 67 PNP inhibitor 67 JAK3 inhibitor 67 Aganocide ® 67 EGS# 67 volociximab 67 XmAb# 67 Behcet uveitis 67 tiapamil 67 siRNA therapeutic 67 YONDELIS R 67 epigenetic therapies 67 Lu AA# 67 OncoGel 67 Phase 1a clinical 67 successfully commercialize Iluvien 67 RhuDex 67 Vernakalant 67 Phase #b/#a clinical 67 Aurora Kinase 67 renin inhibitor 67 targeted antifolate 67 Civacir 67 hyaluronidase enzyme 67 Zybrestat 67 Degarelix 67 TBC# 67 mGluR2 positive 67 Liposomal 67 Zenvia ™ 67 EndoTAG TM -1 67 IMA# 67 DermaVir Patch 67 orally administered inhibitor 67 PGL# 67 DUROS 67 novel prodrug 67 Amplimexon 67 Ampakine 67 Varespladib 67 PRT# 67 GRN# 67 sargramostim 67 sitaxsentan 67 siRNA therapeutics 67 NP2 67 GLP toxicology studies 67 Fodosine 67 CA9 SCAN 67 Arcalyst 67 anti CD3 67 Quinamed 67 IMiDs ® 67 preclinical efficacy 67 indibulin 67 Anticalin ® 67 QTinno TM 67 vascular disrupting agent 67 Emezine 67 ATL/TV# 66 Bicifadine 66 orally dosed 66 histone deacetylase HDAC inhibitor 66 Aviptadil 66 RhuDex R 66 EndoTAG TM 66 Symadex 66 small molecule tyrosine 66 novel immunotherapeutic 66 tubulin inhibitor 66 Pafuramidine 66 Spiegelmer 66 TOCOSOL 66 AAG geldanamycin analog 66 SYGNIS 66 Monoclonal antibody 66 Enkephalin 66 RECOTHROM R 66 Immunotherapeutic 66 histone deacetylase inhibitor 66 MGd 66 preclinically 66 BrachySil TM 66 tolevamer 66 isoform selective 66 mecamylamine 66 TLR agonists 66 HuMax TAC 66 Guanilib 66 Kevetrin ™ 66 YONDELIS 66 PDE inhibitors 66 torezolid phosphate 66 rhMBL 66 vascular disrupting agents 66 Memryte 66 DCCR 66 Soliris eculizumab 66 DCVax R 66 oral taxane 66 intranasal delivery 66 PSMA ADC 66 CINTREDEKIN BESUDOTOX 66 Initiate Clinical Trial 66 COX Inhibiting Nitric Oxide 66 tezampanel 66 beta 1a 66 Micromet BiTE 66 Cogane 66 CYT# potent vascular disrupting 66 PEGylated 66 oral picoplatin 66 HuMax CD4 66 TLK# 66 Corlux 66 Valdoxan 66 orally inhaled 66 Velcade bortezomib 66 donepezil Aricept 66 NTDDS 66 Removab 66 Darinaparsin 66 pharmacological chaperone 66 Octreotide 66 anticancer compound 66 BrachySil ™ 66 rasagiline tablets 66 GIPET 66 R roscovitine 66 Chemokine 66 Oglemilast 66 Meets Primary Endpoint 66 CBLC# 66 CCX# 66 uricase 66 KRN# 66 synthetic siRNA 66 Phase IIb clinical trials 66 Mipomersen 66 Omacetaxine 66 Alferon N 66 BiTE 66 non nucleoside 66 INCB# [001] 66 endothelin antagonist 66 Temsirolimus 66 immune modulatory 66 PEG SN# 66 Prodarsan ® 66 somatostatin analogue 66 HuMax EGFr 66 DOS# 66 systemic RNAi 66 Myocet 66 PET tracers 66 JAK2 inhibitor 66 Campath alemtuzumab 66 lumiliximab 66 LymphoStat B TM 66 Virulizin ® 66 antiangiogenic agent 66 Allovectin 7 66 HCV protease inhibitors 66 OvaRex ® MAb 66 TG# [003] 66 SinuNase ™ 66 Panzem R NCD 66 selective estrogen receptor modulator 66 LentiVector 66 Activity Assay 66 Aliskiren 66 cleavable linker 66 CORT # 66 STEDESA 66 PI3K/Akt pathway inhibitor 66 ospemifene 66 anticoagulant reversing agent 66 SYN# 66 HQK 66 Phase #b/#a trial 66 DDP# 66 JAK inhibitors 66 THR beta agonist 66 CG# [003] 66 Intravenous CP 66 Milnacipran 66 TLR9 agonist 66 acetonide FA 66 ENMD # 66 PSN# [001] 66 RezularTM 66 potent antiproliferative 66 Naproxcinod 66 synthetic retinoid 66 LEVADEX TM 66 Antiangiogenic 66 Romidepsin 66 Iloperidone 66 Octreolin 66 Telatinib 65 PORxin TM 65 KSP inhibitor 65 Interferon Beta 65 Rasagiline 65 anti amnesic 65 Antisense 65 Cathepsin S 65 KNS # 65 AGHD 65 Initiates Clinical 65 Solulin 65 CDP# 65 UPLYSO 65 Factor Xa inhibitor 65 BEMA TM Fentanyl 65 Multiple Ascending Dose 65 TPI ASM8 65 Kamada AAT 65 Zysolin TM 65 TRX1 65 Solorel TM 65 Presents Preclinical 65 Systemic Delivery 65 icatibant 65 selective modulator 65 TH# [003] 65 Azedra TM 65 OncoVEX 65 tumor vascular disrupting 65 Familial Adenomatous Polyposis FAP 65 unoprostone isopropyl 65 molecular imaging radiopharmaceutical 65 Pertuzumab 65 torezolid 65 omega interferon 65 MEK inhibitors 65 Azedra 65 Orally administered 65 Firazyr 65 CCR5 antagonist 65 Nexavar ® 65 MGN# 65 Personalized Immunotherapy 65 orally inhaled migraine 65 atacicept 65 PrevOnco ™ 65 Pruvel 65 Sudhir Agrawal D.Phil 65 radiation sensitizer 65 BGC# 65 Thiarabine 65 epothilone 65 5 HT2C 65 CB2 selective receptor agonist 65 Elagolix 65 NasalFent 65 Aganocide 65 trastuzumab DM1 T DM1 65 Epanova 65 Initiate Phase 65 Liprostin 65 OncoVEX GM CSF 65 MOVIPREP R 65 diarrhea predominant irritable 65 Saforis 65 Catena ® 65 Nektar proprietary 65 AMPK activators 65 Diamyd R 65 corticosteroid dexamethasone 65 Fleximer 65 Glatiramer acetate 65 phase IIa clinical 65 HSP# inhibitors 65 Prodarsan R 65 OXIGON TM 65 Mirapexin 65 Lisofylline LSF 65 OMP #M# 65 vinorelbine tartrate 65 Pyridorin 65 brivaracetam 65 Nanobody ® 65 antiapoptotic 65 Orazol 65 Iluvien TM 65 TELINTRA R 65 treat chronic sinusitis 65 non nucleoside inhibitor 65 chimeric monoclonal antibody 65 HuMax CD# 65 Technosphere ® 65 SPRIX ® 65 JAK Inhibitor 65 therapeutic monoclonal antibodies 65 Iluvien ® 65 Potelligent Technology 65 Phenoptin 65 SUTENT ® 65 glucokinase activator 65 Ostabolin C TM 65 sd rxRNA 65 Anticalins R 65 Evoltra ® 65 Alfacell proprietary ribonuclease 65 Aplidin 65 immune modulating 65 Successfully Completes Phase 65 investigational humanized monoclonal antibody 65 thetreatment 65 AEG# 65 IAP inhibitors 65 NV1FGF 65 Exelixis compounds 65 Cerashield 65 topically administered 65 Glybera R 65 Tezampanel 65 XP #L 65 Dapagliflozin 65 Zingo TM 65 P#X# antagonist 65 hypoxia activated prodrug 65 CCR9 antagonist 65 Aptivus ® 65 Moxifloxacin 65 AAV vector 65 inhaled antibiotic 65 DP VPA 65 adipiplon 65 ProLindac TM 65 thalidomide Thalomid 65 CINQUIL 65 bardoxolone 65 candidate deforolimus 65 candidate TNFerade biologic 65 Bioral 65 romazarit 65 Pagoclone 65 HGS# 65 QRxPharma 65 Fleximer R 65 basal insulin analogue 65 protein biochip 65 selective orally bioavailable 65 Ixabepilone 65 plasmid DNA vaccine 65 Zavesca r 65 IMiDs R 65 Hemospan 65 Vilazodone 65 HepDirect prodrug 65 2DG 65 HuLuc# 65 Perforomist ™ Inhalation Solution 65 OXIGON 65 PROCHYMAL 65 Elocalcitol 65 TransVax tm 65 Generx TM 65 Annamycin 65 kidney urologic 65 potent suppressor 65 LibiGel ® 64 humanized antibody 64 selective A2A adenosine receptor 64 OMNARIS HFA 64 Maxy G# 64 Dasatinib 64 Hsp# Inhibitor 64 CRMD# 64 mediated inhibition 64 CB2 selective 64 XYOTAX TM 64 Files IND 64 ESBA# 64 orally bioavailable 64 SPRYCEL ® 64 XTEN 64 RNAi therapeutic targeting PCSK9 64 Qutenza TM 64 ATL# [001] 64 Relivar 64 Altastaph 64 acyclovir Lauriad R 64 Cimzia ® certolizumab pegol 64 FOLOTYN ® 64 Serdaxin 64 microtubule inhibitor 64 PPAR gamma agonists 64 Zoraxel 64 MNTX 64 receptor tyrosine kinase inhibitor 64 MEK inhibitor 64 Pazopanib 64 bortezomib Velcade 64 sirtuin modulators 64 RAV# 64 Granulocyte Colony Stimulating Factor 64 Icatibant 64 ADAGIO study 64 Initiates Enrollment 64 immatics 64 Glypromate 64 IIa trials 64 ATPace TM 64 targeting CD# 64 JP-#/fipamezole 64 p# inhibitor 64 afamelanotide 64 TKM ApoB 64 AERx iDMS 64 protein tyrosine phosphatase 1B 64 DermaVir 64 pan HDAC inhibitor 64 RNAi therapeutic targeting 64 Initiates Clinical Trials 64 octreotide acetate 64 Thrombin 64 NS#/#A protease 64 obatoclax 64 triphendiol 64 AFFiRiS 64 favorable pharmacokinetic profile 64 schizophrenia CIAS 64 Anidulafungin 64 Transdermal Patch 64 CTAP# Capsules 64 BRAF inhibitors 64 alemtuzumab MS 64 prostanoid 64 Nanobody 64 Genz # 64 vivo potency 64 LB# [003] 64 LEP ETU 64 TriRima 64 monoclonal antibody therapeutics 64 NB S# strontium malonate 64 incyclinide 64 Elvitegravir 64 acadesine 64 ganaxolone 64 LT NS# 64 Gleevec resistant 64 Onalta 64 Synavive 64 Alzhemed TM 64 Pegloticase 64 PDE# inhibitors 64 Avanafil 64 PF # [002] 64 Muraglitazar 64 Drug Candidate 64 exon skipping 64 SILENOR 64 novel histone deacetylase 64 Addrenex 64 Trofex 64 ocular formulation 64 Galantamine 64 busulfan 64 Oral NKTR 64 Prednisporin 64 Tyrima 64 SAR# [004] 64 Zemplar Capsules 64 PEGylated Fab fragment 64 Hepatitis C Virus HCV 64 histamine dihydrochloride 64 Bevasiranib 64 Alequel TM 64 teriflunomide 64 ALGRX 64 Ecallantide 64 Cannabinor 64 Camvia 64 ThGRF 64 lomitapide 64 opioid antagonists 64 Cleviprex TM clevidipine 64 Interferon alpha 64 balsalazide tablet 64 M# rationally 64 cystinosis patients 64 LEAPS TM 64 topical NSAID 64 ALTROPANE 64 Tß4 64 Sanvar 64 rhIGF-I/rhIGFBP-3 64 Initiates Phase II 64 IV Busulfex 64 Solazed TM 64 Oral Spray 64 Liprotamase 64 PN# [001] 64 Vimpat R 64 hypoxia selective 64 Ceflatonin R 64 somatostatin analog 64 novel peptide 64 anticancer agent 64 Apoptone 64 BCR ABL inhibitors 64 NexACT ® 64 topical ophthalmic 64 REMINYL ® 64 gemcitabine Gemzar ® 64 JAK1 64 Ambrisentan 64 cartilage regeneration 64 MyoCell SDF 1 64 midstage clinical 64 siRNAs targeting 64 selective receptor agonist 64 Fx #A 64 eTag assays 64 IPL# 64 CRLX# 64 EVIZON TM 64 MAXY VII 64 Plicera 64 Natalizumab 64 Insegia 64 DXL# 64 ALN PCS 64 sorafenib tablets 64 CB1 antagonists 64 GMX# 64 NeuroSTAT ® 64 HCV RNA polymerase 64 aplindore 64 HDAC Inhibitor 64 plasma kallikrein inhibitor 64 interferon beta therapy 64 HuMax CD#b 64 Harry Palmin President 64 Aclidinium 64 Bucindolol 64 highly selective adenosine 64 Novolimus 64 novel nucleoside analog 64 Frova ® 64 pharmacokinetic PK study 64 oral antiplatelet agent 64 potency selectivity 64 Glybera 64 GVAX ® 64 MoxDuo IR 64 Onalta ™ 64 mGlu2 3 64 tranilast 64 outlicensed 64 evaluating satraplatin 64 Phase 2a Clinical Trial 64 small molecule thrombopoietin 64 Neurodex 64 alvespimycin 64 KIACTA ™ 64 IL# PE#QQR 64 florbetaben 64 platinum chemotherapeutic 64 AQ4N 64 Rotigotine 64 novel topoisomerase 64 metabolite profiling 64 immunosuppressant therapies 64 Capsulution 64 NP2 Enkephalin 64 Marqibo TM 64 etanercept Enbrel 64 vorinostat 64 Evoltra 64 phase IIb III 64 Xerecept 64 ACCLAIM II 64 oral beclomethasone dipropionate 64 TELINTRA 64 aldehyde dehydrogenase ALDH2 deficiency 64 Kahalalide F 64 sodium glucose transporter 64 VA# [002] 64 ELND-#/AZD-# 64 Recombinant Human 64 Panzem NCD 64 Cimzia TM 64 Xcytrin R 64 OX1 64 Interferon beta 1a 64 SUVN 64 acting inhaled anticholinergic 64 huC# DM4 64 XmAb 64 nitric oxide donating prostaglandin 64 Interferon Gamma 64 Proquin XR 64 REG2 64 antigen sparing 64 Litx 64 HyACT 64 Zalypsis 64 immunomodulatory therapy 64 Bosutinib 63 GeneICE 63 BACcel 63 delipidation 63 LHRH antagonist 63 SinuNase 63 novel DACH platinum 63 GW# [003] 63 dasatinib Sprycel 63 lorvotuzumab mertansine 63 nucleotide analog 63 MYDICAR 63 Lisofylline 63 Gamunex C 63 Novel Oral 63 humanized monoclonal antibodies 63 Anticalins ® 63 Colostrinin 63 liprotamase 63 trial evaluating PRX# 63 orally disintegrating 63 GAMMAGARD 63 Valtropin 63 DXL TM 63 dihydrochloride 63 MAb 63 biomodulator 63 metabolite identification 63 GALNS 63 Tyrosine Kinase Inhibitor 63 Xeloda ® 63 CEQ# 63 Sebivo 63 novel orally bioavailable 63 sorafenib Nexavar 63 Fabry Disease 63 AZILECT R 63 ProMune 63 non nucleoside HCV 63 Cand5 63 HuMax 63 tramiprosate 63 rituximab Rituxan 63 IV APAP 63 dextofisopam 63 Phase 2a Trial 63 Orqis Medical 63 Bafetinib 63 EndoTAG 63 seliciclib CYC# 63 Fenretinide 63 HepDirect technology 63 HDL Mimetic Peptide 63 Receives Orphan Drug Designation 63 Presents Preclinical Data 63 IND submission 63 DermTech International 63 Nalmefene 63 BIM #A# 63 NEUGENE R 63 Phase IIB 63 novel VDA molecule 63 depsipeptide 63 Enhanze Technology 63 TRO# 63 Deforolimus 63 Zolpimist ™ 63 prostone 63 Tolvaptan 63 ALTROPANE R 63 Dendreon Provenge 63 fosbretabulin 63 Diasome 63 Firazyr ® 63 sJIA 63 URG# 63 BZL# 63 BAL# [002] 63 Bellicum Pharmaceuticals Inc. 63 small molecule activators 63 iSONEP ™ 63 Donepezil 63 neuronal nicotinic receptor NNR 63 ICA # 63 Nexavar sorafenib tablets 63 noninfectious uveitis 63 Cethrin R 63 Anticalin R 63 Psoraxine R 63 sublingual formulation 63 Trandolapril 63 MKC# MKC# PP 63 droxidopa 63 ZFP Therapeutic TM 63 Adnectin 63 visilizumab 63 beta interferons 63 Aloxi injection 63 selective inhibition 63 DiLA2 63 Morquio 63 Initiates Clinical Trial 63 Sphingomab TM 63 IAP inhibitor 63 drug ISA# 63 Clonicel 63 defensin mimetic antibiotic 63 tanespimycin 63 G#DT 63 anti angiogenic agent 63 Zarnestra 63 Prestara 63 LEVADEX ™ 63 antitumour 63 Carbidopa 63 LNP formulations 63 HSP# inhibitor 63 peripherally acting 63 SCIB1 63 SynCon 63 Viprinex TM 63 ThermoDox R 63 Traficet EN 63 Bortezomib 63 rufinamide 63 erlotinib Tarceva 63 davalintide 63 NovaBay Aganocide compounds 63 imexon 63 NPC 1C 63 lipid nanoparticle 63 Kepivance 63 transmucosal delivery 63 Trobalt 63 Locked Nucleic Acid LNA 63 NuroPro R 63 Bioral Amphotericin B. 63 Bezielle 63 TAFA# 63 TRANSDUR Bupivacaine 63 cediranib 63 XL# anticancer compounds 63 selective antagonist 63 TNF Tumor Necrosis Factor 63 nanopharmaceutical 63 RLY# 63 Ocrelizumab 63 xanthine oxidase inhibitor 63 A3 adenosine receptor 63 Serdolect ® 63 systemic RNAi therapeutic 63 oxypurinol 63 lexidronam injection 63 peptide conjugated 63 Azacitidine 63 Gleevec imatinib mesylate 63 FTY# fingolimod 63 Supernus Pharmaceuticals 63 Phase 2a clinical trials 63 antiangiogenic agents 63 regorafenib 63 Selective Electrochemical Tumor Ablation 63 Campath ® 63 interferon gamma 1b 63 INT# [002] 63 E1 INT TM 63 DepoDur 63 Nitazoxanide 63 REGiMMUNE 63 AeroLEF TM 63 M1 muscarinic 63 macrolide antibiotics 63 sumatriptan DosePro 63 RhuDex TM 63 Prolor 63 KL4 surfactant 63 aerosolized surfactant 63 patented Bioral 63 DACH platinum 63 LAS# [002] 63 Levetiracetam 63 Laquinimod 63 highly selective inhibitor 63 AKT inhibitor 63 eprotirome 63 SGLT2 inhibitors 63 histone deacetylase HDAC 63 glatiramer 63 LEX System 63 pregabalin Lyrica 63 CLORETAZINE TM VNP#M 63 recombinant factor VIIa 63 antidiabetic 63 Tesetaxel 63 platform HDL Mimetic 63 R#/MEM 63 Davanat 63 PDX pralatrexate 63 GSK# [002] 63 Dyloject TM 63 Completes Patient Enrollment 63 Janus kinase 63 liposomal doxorubicin 63 taxane derivative 63 FM VP4 63 forodesine 63 AFFITOME R 63 NADiA 63 theranostic 63 PI3K/mTOR 63 Nexavar sorafenib 63 ALN TTR 63 LEUKINE 63 selective immunoproteasome inhibitor 63 including eniluracil ADH 63 RISPERDAL ® 63 eligen 63 XL# XL# 63 OREXIGEN 63 Sphingomab 63 ulimorelin 63 direct thrombin inhibitors 63 anticancer therapeutics 63 Avicena 63 ghrelin antagonist 63 CytoFabTM 63 lucinactant 63 EndoTAGTM 1 63 Nasulin ™ 63 Vidaza R 63 paclitaxel poliglumex 63 oxybutynin gel 63 RPL# 63 KL4 Surfactant 63 ARRY # 63 HuCAL antibodies 63 systemically administered 63 Collategene 63 vivo validation 63 trastuzumab DM1 63 oral proteasome inhibitor 63 Ramoplanin 63 Bruton tyrosine kinase Btk 63 Vidaza azacitidine 63 oral treprostinil 63 Tesmilifene 63 Phase IIa trials 63 JVRS 63 Prestara TM 63 Somatuline Depot 63 Lenalidomide 63 miRagen 63 OXi# 63 TÎ ² 4 63 GPR# agonists 63 familial hypercholesterolemia FH 63 Fibrillex TM 63 HCD# [002] 63 Gefitinib 63 selective agonist 63 EnVivo 63 opioid induced bowel dysfunction 63 MTP inhibitor 63 CIP TRAMADOL ER 63 Aryplase 63 Lauriad 63 delafloxacin 63 apomorphine hydrochloride 63 PNT# 63 DexaSite 63 cMET 63 Glufosfamide 63 relapsing multiple sclerosis 63 Initiates Phase 2b 63 nicotinic alpha 7 63 Myolimus 63 VIAject R 63 Chrysalin 63 factor VIIa 63 HepeX B 63 Biolimus A9 63 ALN HPN 63 CGEN # 63 partial agonist 63 antiangiogenesis 63 noscapine 63 miconazole Lauriad ® 63 MediGene focuses 63 antiplatelet agent 63 topical gel containing 63 MAA submission 63 ANYARA 63 Optiquel ™ 63 Combunox 63 NurOwn 63 fibrotic disease 63 QuadraSphere 63 Adentri 63 Solazed 63 aripiprazole Abilify 63 Mersana 63 BioMarck 63 2 methoxyestradiol 63 mTOR inhibitor 63 Thiovir 63 human microdosing 63 selective kinase inhibitor 63 ZK EPO 63 Xyfid TM 63 gefitinib Iressa 63 Ropinirole 63 Cardio Vascu Grow 63 EXPAREL TM 63 Ophena 63 Golimumab 63 multitargeted 63 hPTH #-# 63 GAP #B# 63 MKC#